ANALISIS PELAYANAN KEFARMASIAN DI APOTEK PROVINSI DKI JAKARTA PADA MASA PANDEMI COVID-19
ANALYSIS OF PHARMACEUTICAL SERVICES IN COMMUNITY PHARMACIES IN DKI JAKARTA DURING COVID-19 PANDEMIC
DOI:
https://doi.org/10.37090/jfl.v14i1.2307Abstract
The COVID-19 pandemic has caused changes to pharmaceutical services activities in community pharmacies, due to various adjustments that must be made. To analyze the impact of COVID-19 pandemic on pharmaceutical service activities in community pharmacies. Cross-sectional approach involving community pharmacist in DKI Jakarta. The quantitative data were collected through distributing online questionnaires in November 2022, while qualitative data were obtained through online in-depth interviews. The quantitative data was analyzed descriptively whereas qualitative data was analyzed using content analysis. Research revealed an increase of 29.4% of pharmacies experiencing out of stock in pharmaceutical supplies compared to before the pandemic. There was a 42.1% decrease indirect Drug Information Services (DIS) compared to before the pandemic. Meanwhile, during the pandmeic a 42.1% increase in online DIS. There were various innovations and strategies done by pharmacies including maximizing the use of digitalization both in the implementation of pharmaceutical services, as well as in promotional activities and online sales of pharmacy productsand. It can be concluded that there are considerable differences in managerial activities and clinical pharmacy services before and during the COVID-19 pandemic, with more digital-based technology involvement in managerial activities and clinical pharmacy services during the pandemic.
Keywords: Pharmaceutical services, Pharmacy, COVID-19, Innovations, Strategic
Downloads
References
[1] S. Supardi, Y. Yuniar, and I. D. Sari, “Pelaksanaan Standar Pelayanan Kefarmasian di Apotek di Beberapa Kota Indonesia,” J. Penelit. dan Pengemb. Pelayanan Kesehat., vol. 3, no. 3, pp. 152–159, 2020, doi: 10.22435/jpppk.v3i3.3177.
[2] Kementerian Kesehatan Republik Indonesia, Pedoman Pembinaan dan Pengawasan Fasilitas Pelayanan Kefarmasian, 2021st ed. .
[3] G. W. Targanski et al., “Pengetahuan, Kesadaran, dan Praktik Apoteker di Komunitas di Masa Pandemi COVID-19 di Beberapa Wilayah di Indonesia,” J. Farm. Komunitas, vol. 9, no. 1, pp. 51–58, 2022, doi: 10.20473/jfk.v9i1.24131.
[4] S. Roro, “Optimasi Media Sosial dalam Meningkatkan Penjualan dimasa Pembatasan Sosial Berskala Besar,” vol. 6, no. 1, pp. 121–131, 2021.
[5] A. E. Andriani and S. Sulistyorini, “Penggunaan Media Sosial di Kalangan Mahasiswa Selama Pandemi Covid-19,” Equilib. J. Pendidik., vol. 10, no. 1, pp. 63–70, 2022, doi: 10.26618/equilibrium.v10i1.6442.
[6] A. Widhiarso, “Telemedicine dan Telepharmacy : Tantangan dan Perkembangan di Masa Pandemi COVID - 19,” J. Farm. Dan Kesehat. Indones., vol. 1, no. 1, 2021, doi: 10.61179/jfki.v1i1.152.
[7] E. Hikmawati, “Sistem Informasi Monitoring Pengadaan & Penjualan Obat Pada Apotek Pusat Dan Cabang,” NARATIF (Jurnal Ilm. Nas. Ris. Apl. dan Tek. Inform., vol. 1, no. 1, pp. 1–8, 2019.
[8] D. Retnoningsih, A. Susanto, and A. A. Barlian, “Gambaran Strategi Pengadaan Sediaan Farmasi Apotek Putri Gumayun di Masa Pandemi COVID-19,” Bhamada J. Ilmu dan Teknol. Kesehat., vol. 13, no. 1, pp. 43–51, 2022, doi: 10.36308/jik.v13i1.359.
[9] Menteri Dalam Negeri, “Instruksi Menteri Dalam Negeri Nomor 01 tentang Pemberlakukan Pembatasan Kegiatan untuk Pengendalian Penyebaran Corona Virus Disease (COVID-19),” Kementerian Dalam Negeri Republik Indonesia. pp. 1–4, 2021.
[10] A. Rosyid, N. Febrinasari, and Y. K. Qotimah, “Tingkat Kepuasan Pelayanan Kefarmasian di Apotek Wilayah Kota Semarang Selama Pandemi COVID-19,” vol. 25, no. 3, pp. 109–111, 2021, doi: 10.20956/mff.v25i3.18058.
[11] H. Singh, A. Majumdar, and N. Malviya, “E-Pharmacy Impacts on Society and Pharma Sector in Economical Pandemic Situation: A Review,” J. Drug Deliv. Ther., vol. 10, no. 3-s, pp. 335–340, 2020, doi: 10.22270/jddt.v10i3-s.4122.
[12] A. E. Gross and C. MacDougall, “Roles of the clinical pharmacist during the COVID-19 pandemic,” JACCP J. Am. Coll. Clin. Pharm., vol. 3, no. 3, pp. 564–566, 2020, doi: 10.1002/jac5.1231.
[13] M. M. Fathoni et al., “Pelayanan Kefarmasian Di beberapa Apotek Di Indonesia pada Era Pandemi Covid-19,” J. Farm. Komunitas, vol. 8, no. 2, p. 45, 2021, doi: 10.20473/jfk.v8i2.24135.
[14] D. R. Indika and C. Jovita, “Media Sosial Instagram Sebagai Sarana Promosi Untuk Meningkatkan Minat Beli Konsumen,” J. Bisnis Terap., vol. 1, no. 01, pp. 25–32, 2017, doi: 10.24123/jbt.v1i01.296.
[15] R. Yustiani et al., “Ilmiah Komputer dan Peran Marketplace Sebagai Alternatif Bisnis di Era Teknologi Informasi,” vol. 6, no. 2, 2017.
[16] H. S. Agus Dwi Cahya, Fadhilla Ajeng Aqdella, Asfarina Zahrotul Jannah, “Memanfaatkan Market Place Sebagai Media Promosi untuk Meningkatkan Penjualan di Tengah Pandemi COVID-19,” vol. 4, no. 3, pp. 503–510, 2021.
[17] Kementrian Kesehatan Republik Indonesia, “Peraturan Menteri Kesehatan Republik Indonesia Nomor 26 Tahun 2018 Tentang Pelayanan Perizinan Berusaha Terintegrasi Secara Elektronik Sektor Kesehatan,” vol. 1, no. 1, pp. 1–8, 2018, [Online]. Available: http://dx.doi.org/10.1016/j.cirp.2016.06.001%0Ahttp://dx.doi.org/10.1016/j.powtec.2016.12.055%0Ahttps://doi.org/10.1016/j.ijfatigue.2019.02.006%0Ahttps://doi.org/10.1016/j.matlet.2019.04.024%0Ahttps://doi.org/10.1016/j.matlet.2019.127252%0Ahttp://dx.doi.o.
[18] A. Farid et al., “Efektivitas Penggunaan Layanan Telefarmasi di Era Pandemi COVID-19 dari Perspektif Masyarakat,” J. Farm. Komunitas, vol. 9, no. 2, pp. 152–157, 2022, doi: 10.20473/jfk.v9i2.32924.
[19] A. D. Sasanti, L. Maharani, N. K. Sholihat, T. A. Purwonugroho, I. Mustikaningtias, and D. L. Ilma, “Analisis Kualitatif Mengenai Peran dan Perilaku Apoteker di Apotek Terkait Penggunaan Telefarmasi Selama Pandemi COVID-19,” JPSCR J. Pharm. Sci. Clin. Res., vol. 7, no. 2, p. 149, 2022, doi: 10.20961/jpscr.v7i2.55878.
[20] S. I. P. Yuwana, “Digital Marketing : Strategi Promosi Apotek Sawojajar Mas,” Reinf. J. Sharia Manag., vol. 1, no. 2, pp. 81–91, 2022, doi: 10.21274/reinforce.v1i2.6392.
[21] H. Ismail, V. D. Marshall, M. Patel, M. Tariq, and R. A. Mohammad, “The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases,” J. Am. Pharm. Assoc., vol. 62, no. 3, pp. 834-839.e1, 2022, doi: 10.1016/j.japh.2021.11.013.
[22] S. qian Zheng, L. Yang, P. xiang Zhou, H. bo Li, F. Liu, and R. sheng Zhao, “Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective,” Research in Social and Administrative Pharmacy, vol. 17, no. 1. Elsevier, pp. 1819–1824, 2021, doi: 10.1016/j.sapharm.2020.03.012.
[23] S. Liu et al., “Providing pharmacy services during the coronavirus pandemic,” Int. J. Clin. Pharm., vol. 42, no. 2, pp. 299–304, 2020, doi: 10.1007/s11096-020-01017-0.
